Tectonic Therapeutic, Inc.·4

Mar 9, 6:15 PM ET

Ruddy Marcella K. 4

4 · Tectonic Therapeutic, Inc. · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Tectonic Therapeutic CMO Marcella K. Ruddy Sells 10,000 Shares

What Happened

  • Marcella K. Ruddy, Chief Medical Officer of Tectonic Therapeutic, sold 10,000 shares on 2026-03-06 at $30.00 per share, for total proceeds of $300,000. The Form 4 reports the disposition as an open-market or private sale (code S).

Key Details

  • Transaction date and price: 2026-03-06 — 10,000 shares at $30.00 each.
  • Total value: $300,000.
  • Shares owned after transaction: Not specified in the provided summary — check the full Form 4 on the SEC EDGAR site for current holdings.
  • Footnote: Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2025.
  • Filing/timeliness: Form filed 2026-03-09 for a 2026-03-06 transaction; this filing appears timely (within standard Form 4 reporting window).

Context

  • This was a sale under a pre-established 10b5-1 plan, which typically indicates the transaction was preplanned and may be routine rather than a reaction to company-specific news. Sales are common and less informative than purchases for gauging insider sentiment; retail investors should review the full Form 4 and the insider’s remaining holdings for fuller context.

Insider Transaction Report

Form 4
Period: 2026-03-06
Ruddy Marcella K.
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    [F1]
    2026-03-06$30.00/sh10,000$300,00069,747 total
Footnotes (1)
  • [F1]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 8, 2025.
Signature
/s/ Daniel Lochner, Attorney-in-Fact|2026-03-09

Documents

1 file
  • 4
    form4-03092026_100315.xmlPrimary